Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study of Immediate Versus Luteal Phase Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-positive Breast Cancer

NCT00201851 is registered in ClinicalTrials.gov with International Breast Cancer Research Foundation as lead sponsor.

NCT NCT00201851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00201851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study of Immediate Versus Luteal Phase Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-positive Breast Cancer
Lead sponsor
International Breast Cancer Research Foundation
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2004
Completion date
May 31, 2013
Enrollment
740 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer